MedPath

Podofilox

Content Updated: June 2018

Approved
Approval ID

e4a1e4c4-46b5-4059-8075-951c2347a7a8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 15, 2023

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Podofilox

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63629-8832
Application NumberNDA019795
Product Classification
M
Marketing Category
C73605
G
Generic Name
Podofilox
Product Specifications
Route of AdministrationTOPICAL
Effective DateJanuary 20, 2022
FDA Product Classification

INGREDIENTS (4)

PODOFILOXActive
Quantity: 5 mg in 1 mL
Code: L36H50F353
Classification: ACTIB
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
LACTIC ACID, UNSPECIFIED FORMInactive
Code: 33X04XA5AT
Classification: IACT
SODIUM LACTATEInactive
Code: TU7HW0W0QT
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Podofilox - FDA Drug Approval Details